• Home
  • Search
  • Data from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
  • Open Access IconOpen Access
  • https://doi.org/10.1158/0008-5472.c.6507300Copy DOI Icon

Data from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells

  • Mar 30, 2023
  • Sarah E Alford +9 more
Show More
  • Abstract
  • Literature Map
  • Similar Papers
Abstract

<div>Abstract<p>BH3 mimetic drugs may be useful to treat acute lymphoblastic leukemia (ALL) but the sensitivity of primary tumor cells has not been fully evaluated. Here, B-lineage ALL cell cultures derived from a set of primary tumors were studied with respect to sensitivity to the BH3 mimetics ABT-263 and ABT-199 and to Bcl-2 dependence and function. These ALL cells each expressed high levels of Bcl-2 and exhibited great sensitivity to ABT-263 and ABT-199, which induced rapid apoptotic cell death. BH3 profiling indicated that the ALL cultures were Bcl-2 dependent. Coimmunoprecipitation studies revealed a multifaceted role for Bcl-2 in binding proapoptotic partners including Bax, Bak, Bik, and Bim. ABT-263 disrupted Bcl-2:Bim interaction in cells. Mcl-1 overexpression rendered ALL cells resistant to ABT-263 and ABT-199, with Mcl-1 assuming the role of Bcl-2 in binding Bim. Freshly isolated pediatric ALL blasts also expressed high levels of Bcl-2 and exhibited high sensitivity to Bcl-2 inhibition by the BH3 mimetic compounds. Overall, our results showed that primary ALL cultures were both more sensitive to BH3 mimetics and more uniform in their response than established ALL cell lines that have been evaluated previously. Furthermore, the primary cell model characterized here offers a powerful system for preclinical testing of novel drugs and drug combinations to treat ALL. <i>Cancer Res; 75(7); 1366–75. ©2015 AACR</i>.</p></div>

Similar Papers
  • Research Article
  • Citations46

Lack of CD24 Antigen Expression in B-Lineage Acute Lymphoblastic Leukemia Is Associated With Intrinsic Radiation Resistance of Primary Clonogenic Blasts

  • Mar 01, 1993
  • Blood
  • Fm Uckun +1
  • Abstract
  • Citations1

PO-068 Determining how distinct microenvironments alter BCL-2 family dependence in T-cell acute lymphoblastic leukaemia

  • Jul 01, 2018
  • ESMO Open
  • A Di Grande +3
  • Abstract
  • Citations2

Mesenchymal Cells Determine the Response of Acute Lymphoblastic Leukemia Cells to L-Asparaginase.

  • Nov 16, 2006
  • Blood
  • Shotaro Iwamoto +4
  • Abstract

PO-072 ω3-Polyunsaturated fatty acids inhibit cell growth and invasion of human hypopharyngeal carcinoma cells

  • Jul 01, 2018
  • ESMO Open
  • S.H Han +7
  • Abstract

CITED2 Facilitates Apoptosis Induced By Histone Deacetylase Inhibitor SAHA In Human Pediatric Pre-B Acute Lymphoblastic Leukemia Cells

  • Nov 15, 2013
  • Blood
  • Jinwei Du +2
  • Research Article
  • Citations4

Cyclosporin A Induces Apoptosis in Childhood Acute Lymphoblastic Leukemia Cells

  • Feb 01, 1998
  • Blood
  • Chikako Ito +5
  • Research Article
  • Citations1

Pre-clinical studies and phase I clinical trial of the anti-CD22 immunotoxin CAT-3888 (BL22) for pediatric acute lymphoblastic leukemia (ALL)

  • Jun 20, 2007
  • Journal of Clinical Oncology
  • A Wayne +7
  • Research Article
  • Citations14

Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia

  • Nov 17, 2011
  • Experimental Hematology
  • Naveed I Khan +4
  • Research Article

Abstract 4356: Cytotoxicity of the anti-CD22 immunotoxin HA22 against pediatric acute lymphoblastic leukemia (ALL)

  • Apr 15, 2010
  • Cancer Research
  • Francis J Mussai +8
  • Abstract

Heme Oxygenase-1 in Leukemia Cells Promotes Cancer Associated Fibroblasts Mediating Progression of Acute Lymphoblastic Leukemia

  • Nov 13, 2019
  • Blood
  • Chengyun Pan +4
  • Abstract
  • Citations3

Next-Generation NAMPT Inhibitors For ALL Identified By Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens

  • Nov 15, 2013
  • Blood
  • Michael C Wei +13
  • Abstract
  • Citations3

CD22 Expression in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

  • Nov 20, 2009
  • Blood
  • Armin G Jegalian +6
  • Research Article
  • Citations10

Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia

  • Jul 15, 1994
  • Blood
  • Jc Barredo +6
  • Research Article

Abstract 3951: AKT inhibitor capivasertib combines with dexamethasone and venetoclax to enhance anti-tumor responses in the preclinical models of childhood acute lymphoblastic leukemia

  • Apr 21, 2025
  • Cancer Research
  • Brandon Willis +5
  • Abstract

The Splenic Microenvironment Is a Novel Site of Relapse Following ABT-199 Treatment

  • Nov 13, 2019
  • Blood
  • Alessandra Di Grande +3
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.